Bayzed Health Group Inc (HKG:2609)
Hong Kong · Delayed Price · Currency is HKD 3.015
-0.045 (-1.47%)
Sep 2, 2026, 4:08 PM HKT
Bayzed Health Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,130 | 1,120 | 1,189 | 1,072 | 802.65 | 461.59 | |
Revenue Growth | -5.29% | -5.80% | 10.88% | 33.58% | 73.89% | - |
Cost of Revenue | 936.51 | 929.04 | 980.65 | 894.01 | 723.1 | 420.2 |
Gross Profit | 193.06 | 190.81 | 208.2 | 178.16 | 79.56 | 41.39 |
Selling, General & Admin | 138.91 | 167.7 | 177.53 | 160.64 | 120.61 | 82.54 |
Other Operating Expenses | -7.82 | -2.61 | -2.13 | -4.17 | -3.75 | -1.6 |
Operating Expenses | 132.68 | 165.57 | 176.05 | 156.74 | 118.92 | 81.4 |
Operating Income | 60.38 | 25.24 | 32.15 | 21.42 | -39.36 | -40.01 |
Interest Expense | -20.78 | -21.53 | -21.5 | -26.66 | -23.62 | -20.95 |
Interest & Investment Income | 4.03 | 4.03 | 2.84 | 1.19 | 1.32 | 5.9 |
Currency Exchange Gain (Loss) | 1.61 | 1.61 | - | - | - | - |
Other Non Operating Income (Expenses) | -0.05 | -0.05 | -0.18 | -0.39 | -0.82 | -0.11 |
EBT Excluding Unusual Items | 45.19 | 9.3 | 13.31 | -4.43 | -62.48 | -55.17 |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | 0 | -0.18 | -0.04 | 0.33 |
Pretax Income | 45.18 | 9.29 | 13.31 | -4.61 | -62.52 | -54.84 |
Income Tax Expense | 15.13 | 17.97 | 16.87 | 19.8 | 12.99 | 7.12 |
Earnings From Continuing Operations | 30.05 | -8.68 | -3.56 | -24.41 | -75.52 | -61.96 |
Minority Interest in Earnings | -0.97 | -4.28 | -9.9 | -1.98 | 17.5 | 15.86 |
Net Income | 29.08 | -12.96 | -13.46 | -26.39 | -58.02 | -46.09 |
Net Income to Common | 29.08 | -12.96 | -13.46 | -26.39 | -58.02 | -46.09 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,286 | 1,255 | 1,185 | 1,185 | - | - |
Shares Outstanding (Diluted) | 1,286 | 1,255 | 1,185 | 1,185 | - | - |
Shares Change | -2.48% | 5.91% | - | - | - | - |
EPS (Basic) | 0.02 | -0.01 | -0.01 | -0.02 | - | - |
EPS (Diluted) | 0.02 | -0.01 | -0.01 | -0.02 | - | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 188.9 | 124.67 | 83 | 84.96 | -42.65 |
Free Cash Flow Per Share | - | 0.15 | 0.10 | 0.07 | - | - |
Gross Margin | 17.09% | 17.04% | 17.51% | 16.62% | 9.91% | 8.97% |
Operating Margin | 5.34% | 2.25% | 2.70% | 2.00% | -4.90% | -8.67% |
Profit Margin | 2.57% | -1.16% | -1.13% | -2.46% | -7.23% | -9.98% |
Free Cash Flow Margin | - | 16.87% | 10.49% | 7.74% | 10.59% | -9.24% |
EBITDA | 119.53 | 85.88 | 90.84 | 80.99 | 10.62 | -8.77 |
EBITDA Margin | 10.58% | 7.67% | 7.64% | 7.55% | 1.32% | -1.90% |
D&A For EBITDA | 59.16 | 60.64 | 58.69 | 59.57 | 49.98 | 31.24 |
EBIT | 60.38 | 25.24 | 32.15 | 21.42 | -39.36 | -40.01 |
EBIT Margin | 5.34% | 2.25% | 2.70% | 2.00% | -4.90% | -8.67% |
Effective Tax Rate | 33.49% | 193.39% | 126.72% | - | - | - |